Skip to content

ALXO

ALX Oncology Holdings Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.01
−0.99%
Ask drillr
0
Insider buys (3m)
3
Insider sells (3m)
-$8.3K
Net value (3m)
+31.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 18, 2026Wong Shelly · officer: SVP, FINANCE AND CAOSale573$1.93
Aug 18, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERSale2,230$1.93
Jul 6, 2026Wong Shelly · officer: SVP, FINANCE AND CAOSale1,404$2.04
Apr 17, 2026Klencke Barbara · officer: Chief Medical OfficerA-Award100,000$1.68
Apr 17, 2026Knight Jeff E. · officer: Chief Dev & Operating OfficerA-Award800,000$1.68
Mar 23, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERSale12,311$2.17
Mar 23, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOSale903$2.17
Mar 5, 2026Klencke Barbara · officer: Chief Medical OfficerA-Award700,000$2.07
Feb 20, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOSale565$2.27
Feb 19, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERF-InKind2,201$2.27
Feb 4, 2026GOODMAN COREY S · director, 10 percent owner: Purchase3,184,713$1.57
Jan 28, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOA-Award192,000$1.48
Jan 28, 2026Shantharam Harish · officer: Chief Financial OfficerA-Award303,000$1.48
Jan 28, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERA-Award912,000$1.48
Jan 21, 2026Takimoto Chris H · directorA-Award40,400$1.32
Jan 21, 2026Sandler Alan B. · directorA-Award10,100$1.32
Jan 21, 2026Curran Daniel J. · directorA-Award16,833$1.32
Jan 21, 2026Garland J. Scott · directorA-Award40,400$1.32
Jan 21, 2026Hemrajani Rekha · directorA-Award40,400$1.32
Jan 21, 2026GOODMAN COREY S · director, 10 percent owner: A-Award40,400$1.32
Jan 7, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOSale3,925$1.11
Oct 16, 2025Pinto Shelly · officer: SVP, FINANCE AND CAOA-Award140,000$1.70
Oct 16, 2025Shantharam Harish · officer: Chief Financial OfficerA-Award198,750$1.70
Oct 16, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERA-Award597,500$1.70
Sep 19, 2025Klencke Barbara · directorA-Award300,000$1.05
Sep 18, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERPurchase21,070$1.07
Sep 18, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERPurchase71,163$1.08
Aug 20, 2025Shantharam Harish · officer: Chief Financial OfficerPurchase75,000$0.78
Aug 19, 2025Pinto Shelly · officer: SVP, FINANCE AND CAOSale611$0.64
Aug 19, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERSale2,382$0.64
Institutional positioning

13F filings over the trailing two quarters

New 25Increased 17Reduced 17Sold out 69
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.New Position13,011,849May 15, 2026
TCG CROSSOVER MANAGEMENT, LLCNew Position13,011,849May 15, 2026
VENBIO PARTNERS LLCIncreased12,884,638May 15, 2026
REDMILE GROUP, LLCIncreased7,964,188May 15, 2026
BLACKSTONE INC.New Position5,826,544May 15, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased5,734,620May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position4,179,736May 15, 2026
MARSHALL WACE, LLPIncreased3,757,216May 15, 2026
VIVO CAPITAL, LLCNew Position3,184,713May 20, 2026
ALMITAS CAPITAL LLCIncreased3,173,834May 15, 2026
5AM VENTURE MANAGEMENT, LLCNew Position3,057,325May 15, 2026
ORBIMED ADVISORS LLCNew Position2,866,256May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.New Position2,000,000May 15, 2026
MILLENNIUM MANAGEMENT LLCReduced1,988,559May 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased1,587,833May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026